A Study to Compare Genetic Variations of IGF-I and IGF-II

Completed

Conditions studied: Dementia

In brief

The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of the AD patients and individuals without AD matched by age to the AD patients.

Key facts

Study ID

NCT01329523

Run by

Avera McKennan Hospital & University Health Center

People needed

50

Starts

2010-11-01

Expected to finish

2011-10-01

Last updated by the study team

2011-10-06

Who can join

Age: 50 and older, up to 81. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men and women between the ages of 50 and 81 years old who have a diagnosis of dementia
• Men and women who are at least 18 years old and are biologically related to the study subject with dementia
• Control subjects must not have a diagnosis of dementia and must be matched in age to the study subjects with dementia

You may not qualify if…

• Biological family members of the dementia patient who are either younger than 17 years of age or older than the patient with dementia
• Biological family members with a diagnosis of dementia
• Age-matched control subjects with a diagnosis of dementia

Where it is running

• Avera Research Institute — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.